Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FTBLR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,233
Award facts
- Contract value 100% obligated
- $68,232.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pen injections, with a contract ceiling value of $68,232.65. This firm fixed-price delivery order, awarded on September 25, 2025, represents a non-set-aside competitive procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical prime vendor contract through December 2026 that enables the company to supply a broad range of medications, vaccines, and medical supplies to support military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse medical supply requirements through open competition, with past delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical devices. This particular delivery order for Wegovy—an injectable diabetes medication—continues AmerisourceBergen's support of federal healthcare initiatives under its established DLA framework.
Quick answers
Who was awarded contract SPE2DB25FTBLR?
SPE2DB25FTBLR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FTBLR worth?
The government has obligated $68,233 on SPE2DB25FTBLR.
Is contract SPE2DB25FTBLR an order under another contract?
Yes. SPE2DB25FTBLR is a delivery order under SPE2DB25D3202, an indefinite delivery contract.
Was contract SPE2DB25FTBLR competed?
The extent of competition for SPE2DB25FTBLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award